Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-25-014005
Filing Date
2025-08-11
Accepted
2025-08-08 21:36:32
Documents
8
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 6353
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 396174
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 157250
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 7562
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 7553
6 GRAPHIC exhibit99-2x002.jpg GRAPHIC 39308
7 GRAPHIC exhibit99-2x003.jpg GRAPHIC 39792
8 GRAPHIC exhibit99-2x004.jpg GRAPHIC 58537
  Complete submission text file 0001062993-25-014005.txt   765883
Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40997 | Film No.: 251199919
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)